Justin Hales, CEO and founder of Camplify, joins Chris Titley to discuss the company’s evolution from an RV rental marketplace into a broader RV lifecycle business operating across seven countries.

The conversation covers Camplify’s expansion into insurance, managed services and classifieds, its focus on profit led growth and the role of AI across the business. Justin also discusses the company’s relationship with JB Group as a strategic partner and shareholder, changing customer demand and Camplify’s priorities as it works towards its 2030 vision.

----

This content is factual information only, does not contain financial product advice and has not been prepared in consideration of your personal circumstances or needs. Views shared by individuals are their own personal views and not the views of Scoreboard Media. We are not licensed to provide financial product advice and cannot make investment recommendations to you. Investments carry risk. Please consider seeking professional financial advice, and read the relevant disclosure documents, before making any decisions to invest in financial products.

Pointerra and Scoreboard Media are in a commercial arrangement which includes payment for time spent researching, producing, and editing video and podcast content. All questioning is created by Scoreboard Media, not CHL.

In this episode, Chris Titley sits down with Ian Olson, Co-founder and CEO of ASX-listed Pointerra, for a detailed investor deep dive into one of the more under-the-radar infrastructure SaaS stories.

Pointerra sits at the intersection of geospatial data, digital twins, and enterprise software—helping organisations manage massive, complex physical assets across utilities, mining, transport, and energy.

Ian breaks down how the business has evolved from solving data management problems into becoming a critical platform for interpreting and acting on infrastructure data at scale. The conversation explores how digital twins are being adopted across industries, why enterprise customers are increasingly relying on cloud-based workflows, and how Pointerra is positioning itself within that shift.

They also cover:

• The transition from project-based revenue to recurring SaaS models
• Entering and scaling in the US market
• How AI is impacting both product development and go-to-market strategy
• Why customer-led development has shaped the platform
• The long-term opportunity across utilities, mining, and infrastructure

A practical, in-depth discussion on what it actually takes to build and scale a B2B SaaS company in complex, asset-heavy industries.

Disclaimer

This content is factual information only, does not contain financial product advice and has not been prepared in consideration of your personal circumstances or needs. Views shared by individuals are their own personal views and not the views of Sub11. We are not licenced to provide financial product advice and cannot make investment recommendations to you. Investments carry risk. Please consider seeking professional financial advice, and read the relevant disclosure documents, before making any decisions to invest in financial products.

Pointerra and Sub11 are in a commercial arrangement which includes time spent researching, producing, and editing video and podcast content. All questioning is created by Sub11, not Pointerra.

🎙️ Sub11: Control Bionics — EMG, Impact & Innovation

In this episode of Sub11, Chris Titley sits down with Jeremy Steele, CEO of ASX-listed medtech company Control Bionics.

Jeremy unpacks how a pioneering Australian technology—originally used by Stephen Hawking—is now changing lives across assistive communication, rehabilitation, and sports performance. From enabling non-verbal individuals to communicate, to boosting vertical jump height in elite athletes, Control Bionics is using surface electromyography (EMG) to interpret human intent like never before.

We discuss:

• How the NeuroNode and NeuroStrip work
• Partnerships and global expansion
• Their recent investment in NeuroBounce
• AI’s role in personalised performance and injury prevention
• Commercial traction, regulatory wins, and blue-sky potential

Plus, Jeremy shares a moving story of a young man in Japan who used the technology to speak to his mother for the first time in 20 years.

This is a 101 on a company using Australian-born tech to create global impact.

This content is factual information only, does not contain financial product advice and has not been prepared in consideration of your personal circumstances or needs. Views shared by individuals are their own personal views and not the views of Sub11. We are not licenced to provide financial product advice and cannot make investment recommendations to you. Investments carry risk. Please consider seeking professional financial advice, and read the relevant disclosure documents, before making any decisions to invest in financial products.

Control Bionics and Sub11 are in a commercial relationship which includes the production of media assets for use on LinkedIn. All questioning is created by Sub11, not Control Bionics.